Recombinant multi-species DDX5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DDX5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the DEAD box family of RNA helicases that are involved in a variety of cellular processes as a result of its role as an adaptor molecule, promoting interactions with a large number of other factors. This protein is involved in pathways that include the alteration of RNA structures, plays a role as a coregulator of transcription, a regulator of splicing, and in the processing of small noncoding RNAs. Members of this family contain nine conserved motifs, including the conserved Asp-Glu-Ala-Asp (DEAD) motif, important to ATP binding and hydrolysis as well as RNA binding and unwinding activities. Dysregulation of this gene may play a role in cancer development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2017]
The Alternative Names of target: 2600009A06Rik,DDX5,DEAD box protein 5,Ddx5,G17P1,HLR1,HUMP68,Hlr1,Probable ATP-dependent RNA helicase DDX5,RNA helicase p68,p68

Target products collectionGo to DDX5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T27918-Ag-1/ GM-Tg-hg-T27918-Ag-2 Human DDX5 protein Human
GM-Tg-rg-T27918-Ag-1/ GM-Tg-rg-T27918-Ag-2 Rat DDX5 protein Rat
GM-Tg-mg-T27918-Ag-1/ GM-Tg-mg-T27918-Ag-2 Mouse DDX5 protein Mouse
GM-Tg-cynog-T27918-Ag-1/ GM-Tg-cynog-T27918-Ag-2 Cynomolgus/Rhesus macaque DDX5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T27918-Ag-1/ GM-Tg-felg-T27918-Ag-2 Feline DDX5 protein Feline
GM-Tg-cang-T27918-Ag-1/ GM-Tg-cang-T27918-Ag-2 Canine DDX5 protein Canine
GM-Tg-bovg-T27918-Ag-1/ GM-Tg-bovg-T27918-Ag-2 Bovine DDX5 protein Bovine
GM-Tg-equg-T27918-Ag-1/ GM-Tg-equg-T27918-Ag-2 Equine DDX5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T27918-Ag-1/ GM-Tg-hg-T27918-Ag-2; GM-Tg-rg-T27918-Ag-1/ GM-Tg-rg-T27918-Ag-2;
GM-Tg-mg-T27918-Ag-1/ GM-Tg-mg-T27918-Ag-2; GM-Tg-cynog-T27918-Ag-1/ GM-Tg-cynog-T27918-Ag-2;
GM-Tg-felg-T27918-Ag-1/ GM-Tg-felg-T27918-Ag-2; GM-Tg-cang-T27918-Ag-1/ GM-Tg-cang-T27918-Ag-2;
GM-Tg-bovg-T27918-Ag-1/ GM-Tg-bovg-T27918-Ag-2; GM-Tg-equg-T27918-Ag-1/ GM-Tg-equg-T27918-Ag-2
Products Name DDX5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DDX5
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DDX5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.